Form D · Biotechnology
Sift Biosciences, Inc.
San Carlos, CA · CIK 0002100765
Offering snapshot reported Dec 22, 2025 · SEC filing
- Reported sold
- $3.79M Offering amount: $3.79M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 25, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 22, 2025 | Initial | $3,792,999 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-567817
This filing covers the sale and issuance of Series Pre Seed Preferred Stock, the conversion of certain SAFEs into Series Pre Seed Preferred Stock, and the underlying conversion of such Series Pre Seed Preferred Stock into Common Stock.
Source: Form D, filed Dec 22, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kevin Barrett | Director |
| Yue Lou | Director, Executive |
| Altar Munis | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
7333 Industrial Road
San Carlos, CA, 94070
San Carlos, CA, 94070